{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:34:54Z","timestamp":1790832894008,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accumulating evidence suggests that primary aldosteronism (PA) is associated with several features of the metabolic syndrome, in particular with obesity, type 2 diabetes mellitus, and dyslipidemia. Whether these manifestations are primarily linked to aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism (IHA) remains unclear. The aim of the present study was to investigate differences in metabolic parameters between APA and IHA patients and to assess the impact of treatment on these clinical characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicenter study including 3566 patients with APA or IHA of Caucasian and Asian origin. We compared the prevalence of metabolic disorders between APA and IHA patients at the time of diagnosis and 1-year post-intervention, with special references to sex differences. Furthermore, correlations between metabolic parameters and plasma aldosterone, renin, or plasma cortisol levels after 1 mg dexamethasone (DST) were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As expected, APA patients were characterized by higher plasma aldosterone and lower serum potassium levels. Only female IHA patients demonstrated significantly worse metabolic parameters than age-matched female APA patients, which were associated with lower cortisol levels upon DST. One-year post-intervention, female adrenalectomized patients showed deterioration of their lipid profile, when compared to patients treated with mineralocorticoid receptor antagonists. Plasma aldosterone levels negatively correlated with the BMI only in APA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metabolic alterations appear more prominent in women with IHA. Although IHA patients have worse metabolic profiles, a correlation with cortisol autonomy is documented only in APAs, suggesting an uncoupling of cortisol action from metabolic traits in IHA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-22-0040","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T14:04:57Z","timestamp":1656943497000},"page":"361-372","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":21,"title":["The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex \u2013 a multicenter-study of 3566 Caucasian and Asian subjects"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-2275","authenticated-orcid":true,"given":"Ariadni","family":"Spyroglou","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsSpital Z\u00fcrich (USZ) and Universit\u00e4t Z\u00fcrich (UZH), Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Handgriff","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schwarzlm\u00fcller","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Parasiliti-Caprino","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina Teresa","family":"Fuss","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Remde","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Endokrinologie in Charlottenburg, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Matthew","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, St Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Thuzar","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Petramala","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, University of Rome \u2018Sapienza\u2019, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, University of Rome \u2018Sapienza\u2019, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Deflorenne","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital europ\u00e9en Georges-Pompidou, Universit\u00e9 de Paris, PARCC, Inserm, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital europ\u00e9en Georges-Pompidou, Universit\u00e9 de Paris, PARCC, Inserm, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"Vrckovnik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Kocjan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitabh","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-8645","authenticated-orcid":true,"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-1671","authenticated-orcid":true,"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[{"name":"Endokrinologie in Charlottenburg, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maccario","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Drake","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, St Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":true,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":true,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":true,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"Endocrine Center and Clinical Research Center, Ijinkai Takeda General Hospital, Kyoto, Japan"},{"name":"Clinical Research Institute of Endocrinology and Metabolism, NHO Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":true,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsSpital Z\u00fcrich (USZ) and Universit\u00e4t Z\u00fcrich (UZH), Zurich, Switzerland"},{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"bib1","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","unstructured":"Brown JMSiddiqui MCalhoun DACarey RMHopkins PNWilliams GHVaidya A. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Annals of Internal Medicine202017310\u201320. (https:\/\/doi.org\/10.7326\/M20-0065)10.7326\/M20-0065"},{"key":"bib2","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","unstructured":"Hannemann ABidlingmaier MFriedrich NManolopoulou JSpyroglou AVolzke HBeuschlein FSeissler JRettig RFelix SBScreening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. European Journal of Endocrinology20121677\u201315. (https:\/\/doi.org\/10.1530\/EJE-11-1013)10.1530\/EJE-11-1013"},{"key":"bib3","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","unstructured":"Funder JWCarey RMMantero FMurad MHReincke MShibata HStowasser MYoung Jr WF. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism20161011889\u20131916. (https:\/\/doi.org\/10.1210\/jc.2015-4061)10.1210\/jc.2015-4061"},{"key":"bib4","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry","volume":"173","author":"Hanslik","year":"2015","unstructured":"Hanslik GWallaschofski HDietz ARiester AReincke MAllolio BLang KQuack IRump LCWillenberg HSIncreased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. European Journal of Endocrinology2015173665\u2013675. (https:\/\/doi.org\/10.1530\/EJE-15-0450)10.1530\/EJE-15-0450"},{"key":"bib5","series-title":"Archives of Internal Medicine","first-page":"1745","article-title":"Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the Atherosclerosis Risk in Communities (ARIC) study","volume":"170","author":"Chatterjee","year":"2010","unstructured":"Chatterjee RYeh HCShafi TSelvin EAnderson CPankow JSMiller EBrancati F. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the Atherosclerosis Risk in Communities (ARIC) study. Archives of Internal Medicine20101701745\u20131751. (https:\/\/doi.org\/10.1001\/archinternmed.2010.362)"},{"key":"bib6","series-title":"Diabetologia","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets","volume":"54","author":"Luther","year":"2011","unstructured":"Luther JMLuo PKreger MTBrissova MDai CWhitfield TTKim HSWasserman DHPowers ACBrown NJ. Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia2011542152\u20132163. (https:\/\/doi.org\/10.1007\/s00125-011-2158-9)10.1007\/s00125-011-2158-9"},{"key":"bib7","series-title":"Hormone and Metabolic Research","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s Registry","volume":"42","author":"Reincke","year":"2010","unstructured":"Reincke MMeisinger CHolle RQuinkler MHahner SBeuschlein FBidlingmaier MSeissler JEndres S & Participants of the German Conn\u2019s Registry. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s Registry. Hormone and Metabolic Research201042435\u2013439. (https:\/\/doi.org\/10.1055\/s-0029-1246189)10.1055\/s-0029-1246189"},{"key":"bib8","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","unstructured":"Akehi YYanase TMotonaga RUmakoshi HTsuiki MTakeda YYoneda TKurihara IItoh HKatabami THigh prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan. Diabetes Care201942938\u2013945. (https:\/\/doi.org\/10.2337\/dc18-1293)10.2337\/dc18-1293"},{"key":"bib9","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","unstructured":"Matrozova JSteichen OAmar LZacharieva SJeunemaitre XPlouin PF. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension200953605\u2013610. (https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.122002)10.1161\/HYPERTENSIONAHA.108.122002"},{"key":"bib10","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","unstructured":"Fallo FVeglio FBertello CSonino NDella Mea PErmani MRabbia FFederspil GMulatero P. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. Journal of Clinical Endocrinology and Metabolism200691454\u2013459. (https:\/\/doi.org\/10.1210\/jc.2005-1733)10.1210\/jc.2005-1733"},{"key":"bib11","series-title":"Journal of Diabetes Investigation","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/jdi.13312","article-title":"Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: aldosterone-producing adenoma and idiopathic hyperaldosteronism","volume":"11","author":"Okazaki-Hada","year":"2020","unstructured":"Okazaki-Hada MMoriya ANagao MOikawa SFukuda ISugihara H. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: aldosterone-producing adenoma and idiopathic hyperaldosteronism. Journal of Diabetes Investigation2020111511\u20131519. (https:\/\/doi.org\/10.1111\/jdi.13312)10.1111\/jdi.13312"},{"key":"bib12","series-title":"Journal of Hypertension","article-title":"The impact of Connshing\u2019s syndrome \u2013 mild cortisol excess in primary aldosteronism drives diabetes risk","volume":"35","author":"Beuschlein","year":"2017","unstructured":"Beuschlein FReincke MArlt W. The impact of Connshing\u2019s syndrome \u2013 mild cortisol excess in primary aldosteronism drives diabetes risk. Journal of Hypertension201735 2548. (https:\/\/doi.org\/10.1097\/HJH.0000000000001550)"},{"key":"bib13","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion","volume":"104","author":"Gerards","year":"2019","unstructured":"Gerards JHeinrich DAAdolf CMeisinger CRathmann WSturm LNirschl NBidlingmaier MBeuschlein FThorand BImpaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. Journal of Clinical Endocrinology and Metabolism20191043192\u20133202. (https:\/\/doi.org\/10.1210\/jc.2019-00299)10.1210\/jc.2019-00299"},{"key":"bib14","series-title":"JCI Insight","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","unstructured":"Arlt WLang KSitch AJDietz ASRhayem YBancos IFeuchtinger AChortis VGilligan LCLudwig PSteroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight20172 e93136. (https:\/\/doi.org\/10.1172\/jci.insight.93136)"},{"key":"bib15","series-title":"Endocrine Journal","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1507\/endocrj.EJ16-0500","article-title":"Aldosterone excess may inhibit insulin secretion: a comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism","volume":"64","author":"Tsurutani","year":"2017","unstructured":"Tsurutani YSugisawa CIshida AInoue KSaito JOmura MNagasaka SNishikawa T. Aldosterone excess may inhibit insulin secretion: a comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism. Endocrine Journal201764339\u2013346. (https:\/\/doi.org\/10.1507\/endocrj.EJ16-0500)10.1507\/endocrj.EJ16-0500"},{"key":"bib16","series-title":"Journal of Hypertension","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","unstructured":"Wu VCChueh SJChen LChang CHHu YHLin YHWu KDYang WS & TAIPAI Study Group. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years. Journal of Hypertension2017351698\u20131708. (https:\/\/doi.org\/10.1097\/HJH.0000000000001361)10.1097\/HJH.0000000000001361"},{"key":"bib17","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","unstructured":"Bochud MNussberger JBovet PMaillard MRElston RCPaccaud FShamlaye CBurnier M. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension200648239\u2013245. (https:\/\/doi.org\/10.1161\/01.HYP.0000231338.41548.fc)10.1161\/01.HYP.0000231338.41548.fc"},{"key":"bib18","series-title":"International Journal of Endocrinology","article-title":"Physiological aldosterone concentrations are associated with alterations of lipid metabolism: observations from the general population","volume":"2018","author":"Hannich","year":"2018","unstructured":"Hannich MWallaschofski HNauck MReincke MAdolf CVolzke HRettig RHannemann A. Physiological aldosterone concentrations are associated with alterations of lipid metabolism: observations from the general population. International Journal of Endocrinology20182018 4128174. (https:\/\/doi.org\/10.1155\/2018\/4128174)"},{"key":"bib19","series-title":"Obesity Research","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","unstructured":"Goodfriend TLKelley DEGoodpaster BHWinters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obesity Research19997355\u2013362. (https:\/\/doi.org\/10.1002\/j.1550-8528.1999.tb00418.x)10.1002\/j.1550-8528.1999.tb00418.x"},{"key":"bib20","series-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans","volume":"60","author":"Goodfriend","year":"1999","unstructured":"Goodfriend TLEgan BMKelley DE. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins, Leukotrienes, and Essential Fatty Acids199960401\u2013405. (https:\/\/doi.org\/10.1016\/s0952-3278(9980020-9)10.1016\/S0952-3278(99)80020-9"},{"key":"bib21","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","unstructured":"Engeli SBohnke JGorzelniak KJanke JSchling PBader MLuft FCSharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension200545356\u2013362. (https:\/\/doi.org\/10.1161\/01.HYP.0000154361.47683.d3)10.1161\/01.HYP.0000154361.47683.d3"},{"key":"bib22","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2018-00866","article-title":"Obesity as a key factor underlying idiopathic hyperaldosteronism","volume":"103","author":"Ohno","year":"2018","unstructured":"Ohno YSone MInagaki NYamasaki TOgawa OTakeda YKurihara IUmakoshi HIchijo TKatabami TObesity as a key factor underlying idiopathic hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism20181034456\u20134464. (https:\/\/doi.org\/10.1210\/jc.2018-00866)10.1210\/jc.2018-00866"},{"key":"bib23","series-title":"Endocrine Journal","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","unstructured":"Nishikawa TOmura MSatoh FShibata HTakahashi KTamura NTanabe A & Task Force Committee on PrimaryAldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 the Japan Endocrine Society 2009. Endocrine Journal201158711\u2013721. (https:\/\/doi.org\/10.1507\/endocrj.ej11-0133)10.1507\/endocrj.EJ11-0133"},{"key":"bib24","series-title":"Lancet","first-page":"157","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet2004363157\u2013163. (https:\/\/doi.org\/10.1016\/S0140-6736(0315268-3)"},{"key":"bib25","series-title":"Nutrition and Diabetes","article-title":"The need to redefine age- and gender-specific overweight and obese body mass index cutoff points","volume":"5","author":"Nevill","year":"2015","unstructured":"Nevill AMMetsios GS. The need to redefine age- and gender-specific overweight and obese body mass index cutoff points. Nutrition and Diabetes20155 e186. (https:\/\/doi.org\/10.1038\/nutd.2015.36)"},{"key":"bib26","series-title":"European Journal of Clinical Nutrition","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/ejcn.2009.101","article-title":"Associations between gender, age and waist circumference","volume":"64","author":"Stevens","year":"2010","unstructured":"Stevens JKatz EGHuxley RR. Associations between gender, age and waist circumference. European Journal of Clinical Nutrition2010646\u201315. (https:\/\/doi.org\/10.1038\/ejcn.2009.101)10.1038\/ejcn.2009.101"},{"key":"bib27","series-title":"Scientific Reports","article-title":"Optimal cut-off values for anthropometric measures of obesity in screening for cardiometabolic disorders in adults","volume":"10","author":"Macek","year":"2020","unstructured":"Macek PBiskup MTerek-Derszniak MKrol HSmok-Kalwat JGozdz SZak M. Optimal cut-off values for anthropometric measures of obesity in screening for cardiometabolic disorders in adults. Scientific Reports202010 11253. (https:\/\/doi.org\/10.1038\/s41598-020-68265-y)"},{"key":"bib28","series-title":"PNAS","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","unstructured":"Ehrhart-Bornstein MLamounier-Zepter VSchraven ALangenbach JWillenberg HSBarthel AHauner HMcCann SMScherbaum WABornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. PNAS200310014211\u201314216. (https:\/\/doi.org\/10.1073\/pnas.2336140100)10.1073\/pnas.2336140100"},{"key":"bib29","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","unstructured":"Huby ACAntonova GGroenendyk JGomez-Sanchez CEBollag WBFilosa JABelin de Chantemele EJ. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation20151322134\u20132145. (https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018226)10.1161\/CIRCULATIONAHA.115.018226"},{"key":"bib30","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1210\/jc.2009-2204","article-title":"Adipokines and cardiometabolic profile in primary hyperaldosteronism","volume":"95","author":"Iacobellis","year":"2010","unstructured":"Iacobellis GPetramala LCotesta DPergolini MZinnamosca LCianci RDe Toma GSciomer SLetizia C. Adipokines and cardiometabolic profile in primary hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism2010952391\u20132398. (https:\/\/doi.org\/10.1210\/jc.2009-2204)10.1210\/jc.2009-2204"},{"key":"bib31","series-title":"Hypertension Research","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/hr.2011.173","article-title":"Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications","volume":"35","author":"Kalil","year":"2012","unstructured":"Kalil GZHaynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertension Research2012354\u201316. (https:\/\/doi.org\/10.1038\/hr.2011.173)10.1038\/hr.2011.173"},{"key":"bib32","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1210\/jc.2014-2274","article-title":"Leptin and adiponectin mRNA expression from the adipose tissue surrounding the adrenal neoplasia","volume":"100","author":"Letizia","year":"2015","unstructured":"Letizia CPetramala LDi Gioia CRChiappetta CZinnamosca LMarinelli CIannucci GCiardi ADe Toma GIacobellis G. Leptin and adiponectin mRNA expression from the adipose tissue surrounding the adrenal neoplasia. Journal of Clinical Endocrinology and Metabolism2015100E101\u2013E104. (https:\/\/doi.org\/10.1210\/jc.2014-2274)10.1210\/jc.2014-2274"},{"key":"bib33","series-title":"Journal of the Endocrine Society","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/js.2018-00187","article-title":"Relationship Between visceral fat and plasma aldosterone concentration in patients with primary aldosteronism","volume":"2","author":"Shibayama","year":"2018","unstructured":"Shibayama YWada NBaba SMiyano YObara SIwasaki RNakajima HSakai HUsubuchi HTerae SRelationship Between visceral fat and plasma aldosterone concentration in patients with primary aldosteronism. Journal of the Endocrine Society201821236\u20131245. (https:\/\/doi.org\/10.1210\/js.2018-00187)10.1210\/js.2018-00187"},{"key":"bib34","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","unstructured":"Rossi GPBelfiore ABernini GFabris BCaridi GFerri CGiacchetti GLetizia CMaccario MMannelli MBody mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. Journal of Clinical Endocrinology and Metabolism2008932566\u20132571. (https:\/\/doi.org\/10.1210\/jc.2008-0251)10.1210\/jc.2008-0251"},{"key":"bib35","series-title":"Journal of Human Hypertension","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jhh.2010.65","article-title":"The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism","volume":"24","author":"Somloova","year":"2010","unstructured":"Somloova ZWidimsky Jr JRosa JWichterle DStrauch BPetrak OZelinka TVlkova JMasek MDvorakova JThe prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. Journal of Human Hypertension201024625\u2013630. (https:\/\/doi.org\/10.1038\/jhh.2010.65)10.1038\/jhh.2010.65"},{"key":"bib36","series-title":"Journal of Hypertension","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study","volume":"29","author":"Fallo","year":"2011","unstructured":"Fallo FBertello CTizzani DFassina ABoulkroun SSonino NMonticone SViola AVeglio FMulatero P. Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. Journal of Hypertension2011291773\u20131777. (https:\/\/doi.org\/10.1097\/HJH.0b013e32834937f3)10.1097\/HJH.0b013e32834937f3"},{"key":"bib37","series-title":"JCI Insight","article-title":"In situ metabolomics of aldosterone-producing adenomas","volume":"4","author":"Murakami","year":"2019","unstructured":"Murakami MRhayem YKunzke TSun NFeuchtinger ALudwig PStrom TMGomez-Sanchez CKnosel TKirchner TIn situ metabolomics of aldosterone-producing adenomas. JCI Insight20194 e130356. (https:\/\/doi.org\/10.1172\/jci.insight.130356)"},{"key":"bib38","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","unstructured":"Williams TAPeitzsch MDietz ASDekkers TBidlingmaier MRiester ATreitl MRhayem YBeuschlein FLenders JWGenotype-specific steroid profiles associated with aldosterone-producing adenomas. Hypertension201667139\u2013145. (https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06186)10.1161\/HYPERTENSIONAHA.115.06186"},{"key":"bib39","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","article-title":"Worsening of lipid metabolism after successful treatment of primary aldosteronism","volume":"54","author":"Adolf","year":"2016","unstructured":"Adolf CAsbach EDietz ASLang KHahner SQuinkler MRump LCBidlingmaier MTreitl MLadurner RWorsening of lipid metabolism after successful treatment of primary aldosteronism. Endocrine201654198\u2013205. (https:\/\/doi.org\/10.1007\/s12020-016-0983-9)10.1007\/s12020-016-0983-9"},{"key":"bib40","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","unstructured":"Eisenhofer GKurlbaum MPeitzsch MConstantinescu GRemde HSchulze MKaden DMuller LMFuss CTKunz SThe saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy. Journal of Clinical Endocrinology and Metabolism2022107e2027\u2013e2036. (https:\/\/doi.org\/10.1210\/clinem\/dgab924)10.1210\/clinem\/dgab924"},{"key":"bib41","series-title":"Endocrine Journal","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1507\/endocrj.EJ21-0278","article-title":"Comparison and commutability study between standardized liquid chromatography-mass spectrometry\/mass spectrometry (LC-MS\/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood","volume":"69","author":"Nishikawa","year":"2022","unstructured":"Nishikawa TSatoh FTakashi YYanase TItoh HKurihara IShibata HOki YNaruse MSasamoto HComparison and commutability study between standardized liquid chromatography-mass spectrometry\/mass spectrometry (LC-MS\/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood. Endocrine Journal20226945\u201354. (https:\/\/doi.org\/10.1507\/endocrj.EJ21-0278)10.1507\/endocrj.EJ21-0278"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/3\/EJE-22-0040.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/3\/EJE-22-0040.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/3\/EJE-22-0040.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:17:52Z","timestamp":1676373472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/3\/361\/6972065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":41,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-22-0040","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}